Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The tuberculosis treatment market was valued at USD 1.87 Billion in 2025. It is poised to grow at a CAGR of 7.57% during the forecast period of 2026-2035, and reach USD 3.88 Billion by 2035. The market growth is driven by the rising global burden of tuberculosis, the increasing prevalence of drug-resistant TB strains, and growing government and multilateral organization initiatives to accelerate TB elimination.
Base Year
Historical Period
Forecast Period
In November 2024, Daiichi Sankyo highlighted its legacy of pioneering tuberculosis drugs, with such innovations expected to accelerate treatment advancements and drive market growth significantly during the forecast period.
One of the major market trends includes the development of shorter tuberculosis treatment regimens. For instance, in November 2023, the Tuberculosis Trials Consortium launched the CRUSH-TB trial to evaluate four-month drug combinations, improving adherence and driving market growth.
In March 2024, the United States Agency for International Development committed USD 1.5 million for TB preventive treatment in Indonesia, expanding access and accelerating adoption of cost-effective regimens, thereby supporting market growth.
The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Johnson & Johnson Innovation Inc.
Johnson & Johnson Innovation Inc. contributes to tuberculosis control by combining awareness efforts with improved treatment access. The company backs initiatives like MTV Nishedh in India to promote early diagnosis and reduce social stigma. It also facilitates broader availability of bedaquiline for multidrug-resistant TB while partnering globally to enhance healthcare infrastructure and treatment outreach.
Pfizer Inc.
Pfizer Inc. supports tuberculosis management through Wyeth Pharmaceuticals LLC by offering Trecator® (ethionamide tablets, USP). This oral medication is used in treating active and drug-resistant TB cases as part of combination therapies. Its use helps improve clinical outcomes, reflecting Pfizer’s role in combating antimicrobial resistance and strengthening therapeutic options in tuberculosis care.
Sanofi SA
Sanofi SA addresses tuberculosis through targeted access programs and public health support. Its TB FREE initiative in South Africa emphasizes adherence to treatment using rifampicin-based therapies and DOTS protocols. By focusing on structured care delivery, the company enhances patient outcomes and reinforces its position in improving access to tuberculosis treatments in affected regions.
Eli Lilly and Company
Eli Lilly and Company advances tuberculosis treatment through ongoing investment in research and innovation. By extending funding to the Infectious Disease Research Institute, it supports the development of new therapies for TB and multidrug-resistant strains. The company also shares scientific resources, including compound libraries and expertise, fostering collaboration in the discovery of more effective treatments.
Other key players in the market are AstraZeneca Plc, Viatris Inc. (Mylan N.V.), Teva Pharmaceutical Industries, Ltd., Sun Pharmaceutical, Industries Ltd., Novartis AG, and Hikma Pharmaceuticals PLC.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.